Difference between revisions of "Jiang C, et al. J. Exp. Clin. Cancer Res. (2017) cited as Ref 322 in DOI: 10.1038/s41392-020-0110-5 (Q9585)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: PubMed ID (P140): 28750679, #quickstatements; #temporary_batch_1590001671040)
(‎Created claim: Page(s) (P105): 99-, #quickstatements; #temporary_batch_1590074839150)
 
(4 intermediate revisions by the same user not shown)
Property / Publication Date
 +
2017
Timestamp+2017-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2017 / rank
 +
Normal rank
Property / Published In Name String
 +
J. Exp. Clin. Cancer Res.
Property / Published In Name String: J. Exp. Clin. Cancer Res. / rank
 +
Normal rank
Property / Volume
 +
36
Property / Volume: 36 / rank
 +
Normal rank
Property / title
 +
miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma (English)
Property / title: miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma (English) / rank
 +
Normal rank
Property / Page(s)
 +
99-
Property / Page(s): 99- / rank
 +
Normal rank

Latest revision as of 15:37, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Jiang C, et al. J. Exp. Clin. Cancer Res. (2017) cited as Ref 322 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Jiang C
    0 references
    0 references
    2017
    0 references
    J. Exp. Clin. Cancer Res.
    0 references
    36
    0 references
    miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma (English)
    0 references
    99-
    0 references